This compound is a pharmaceutical intermediate featuring a triazole ring attached to an aniline moiety. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 119192-10-8
(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine
pharmaceutical intermediate
4,5-dichloro-3H-1,2-dithiol-3-one
pharmaceutical intermediate
(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
pharmaceutical intermediate
3-Quinuclidinone hydrochloride
pharmaceutical intermediate
4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile
pharmaceutical intermediate
Anastrozole
pharmaceutical raw material
2-{3-(1-Cyanoethyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]phenyl}-2-methylpropanenitrile
pharmaceutical intermediate
4-(1,2,4-triazol-1-ylmethyl)aniline
ZGLQVRIVLWGDNA-UHFFFAOYSA-N
C1=CC(=CC=C1CN2C=NC=N2)N
—